AAAAAA

   
Results: 1-18 |
Results: 18
PROTEIN A-IMMUNOADSORPTION IN CHEMOTHERAPY ASSOCIATED HEMOLYTIC-UREMIC SYNDROME
Authors: BORGHARDT EJ KIRCHERTZ EJ MARTEN I FENCHEL K
Citation: Ej. Borghardt et al., PROTEIN A-IMMUNOADSORPTION IN CHEMOTHERAPY ASSOCIATED HEMOLYTIC-UREMIC SYNDROME, Transfusion science, 19, 1998, pp. 5-7
INTERLEUKIN-2 REDUCES THE CD4+ CELL DEPLETION FOLLOWING FLUDARABINE AND IDARUBICIN COMBINATION THERAPY
Authors: FENCHEL K HOFFMANN R BORGHARDT J KIRCHNER H PRALLE H GANSER A ATZPODIEN J
Citation: K. Fenchel et al., INTERLEUKIN-2 REDUCES THE CD4+ CELL DEPLETION FOLLOWING FLUDARABINE AND IDARUBICIN COMBINATION THERAPY, British Journal of Haematology, 102(1), 1998, pp. 89-89
FLUDARABINE AND IDARUBICIN FOLLOWED BY IL-2 IN THE TREATMENT OF PRETREATED ADVANCED INDOLENT LYMPHOMA - PRELIMINARY-RESULTS OF A PHASE-II STUDY
Authors: FENCHEL K ATZPODIEN J BORGHARDT EJ GEISSLER RG KIRCHNER H GANSER A
Citation: K. Fenchel et al., FLUDARABINE AND IDARUBICIN FOLLOWED BY IL-2 IN THE TREATMENT OF PRETREATED ADVANCED INDOLENT LYMPHOMA - PRELIMINARY-RESULTS OF A PHASE-II STUDY, Experimental hematology, 25(8), 1997, pp. 408-408
FLUDARABINE AND IDARUBICIN IS THE TREATMENT OF PRETREATED ADVANCED INDOLENT LYMPHOMA - RESULTS OF A PHASE-II STUDY
Authors: ATZPODIEN J FENCHEL K HOFFMANN R BORGHARDT EJ GEISSLER RG ANAGNOU J KIRCHNER H GANSER A
Citation: J. Atzpodien et al., FLUDARABINE AND IDARUBICIN IS THE TREATMENT OF PRETREATED ADVANCED INDOLENT LYMPHOMA - RESULTS OF A PHASE-II STUDY, Blood, 90(10), 1997, pp. 4119-4119
INTERLEUKIN-2 IS EFFECTIVE IN REDUCING THE FLUDARABINE-INDUCED CD4+ CELL DEPLETION
Authors: FENCHEL K ATZPODIEN J BORGHARDT EJ GEISSLER RG HOFFMANN R KIRCHNER H GANSER A
Citation: K. Fenchel et al., INTERLEUKIN-2 IS EFFECTIVE IN REDUCING THE FLUDARABINE-INDUCED CD4+ CELL DEPLETION, Blood, 90(10), 1997, pp. 2278-2278
CLINICAL-EXPERIENCE WITH FLUDARABINE AND ITS IMMUNOSUPPRESSIVE EFFECTS IN PRETREATED CHRONIC LYMPHOCYTIC LEUKEMIAS AND LOW-GRADE LYMPHOMAS
Authors: FENCHEL K BERGMANN L WIJERMANS P ENGERT A PRALLE H MITROU PS DIEHL V HOELZER D
Citation: K. Fenchel et al., CLINICAL-EXPERIENCE WITH FLUDARABINE AND ITS IMMUNOSUPPRESSIVE EFFECTS IN PRETREATED CHRONIC LYMPHOCYTIC LEUKEMIAS AND LOW-GRADE LYMPHOMAS, Leukemia & lymphoma, 18(5-6), 1995, pp. 485-492
CLINICAL-RESULTS OF 2 REGIMENS WITH HIGH-DOSE AND INTERLEUKIN-2 IN ADVANCED RENAL-CELL CANCER AND MALIGNANT-MELANOMA
Authors: FENCHEL K WINKLER A MITROU PS HOELZER D BERGMANN L
Citation: K. Fenchel et al., CLINICAL-RESULTS OF 2 REGIMENS WITH HIGH-DOSE AND INTERLEUKIN-2 IN ADVANCED RENAL-CELL CANCER AND MALIGNANT-MELANOMA, European journal of cancer, 31A, 1995, pp. 52-52
BONE-MARROW-DERIVED T-CELL CLONES OBTAINED FROM UNTREATED ACUTE MYELOCYTIC-LEUKEMIA EXHIBIT BLAST DIRECTED AUTOLOGOUS CYTOTOXICITY
Authors: JAHN B BERGMANN L WEIDMANN E BRIEGER J FENCHEL K SCHWULERA U HOELZER D MITROU PS
Citation: B. Jahn et al., BONE-MARROW-DERIVED T-CELL CLONES OBTAINED FROM UNTREATED ACUTE MYELOCYTIC-LEUKEMIA EXHIBIT BLAST DIRECTED AUTOLOGOUS CYTOTOXICITY, Leukemia research, 19(2), 1995, pp. 73-82
THE EXPRESSION OF THE WILMS-TUMOR GENE IN ACUTE MYELOCYTIC LEUKEMIAS AS A POSSIBLE MARKER FOR LEUKEMIC BLAST CELLS
Authors: BRIEGER J WEIDMANN E FENCHEL K MITROU PS HOELZER D BERGMANN L
Citation: J. Brieger et al., THE EXPRESSION OF THE WILMS-TUMOR GENE IN ACUTE MYELOCYTIC LEUKEMIAS AS A POSSIBLE MARKER FOR LEUKEMIC BLAST CELLS, Leukemia, 8(12), 1994, pp. 2138-2143
FLUDARABINE IS AN EFFECTIVE AGENT IN IMMUNOCYTIC LYMPHOMA
Authors: FENCHEL K WIJERMANS P MITROU PS HOELZER D BERGMANN L
Citation: K. Fenchel et al., FLUDARABINE IS AN EFFECTIVE AGENT IN IMMUNOCYTIC LYMPHOMA, Onkologie, 17(5), 1994, pp. 508-513
IN-VIVO REGULATION OF TRANSFORMING GROWTH-FACTOR-BETA-1 TRANSCRIPTIONBY IMMUNOTHERAPY - INTERLEUKIN-2 IMPAIRS INTERFERON-ALPHA-STIMULATED INCREASE IN STEADY-STATE MESSENGER-RNA LEVELS OF TRANSFORMING GROWTH-FACTOR-BETA-1
Authors: JAHN B BRIEGER J FENCHEL K MITROU PS BERGMANN L
Citation: B. Jahn et al., IN-VIVO REGULATION OF TRANSFORMING GROWTH-FACTOR-BETA-1 TRANSCRIPTIONBY IMMUNOTHERAPY - INTERLEUKIN-2 IMPAIRS INTERFERON-ALPHA-STIMULATED INCREASE IN STEADY-STATE MESSENGER-RNA LEVELS OF TRANSFORMING GROWTH-FACTOR-BETA-1, Cancer immunology and immunotherapy, 38(5), 1994, pp. 304-310
IMMUNOSUPPRESSIVE EFFECTS AND CLINICAL-RESPONSE OF FLUDARABINE IN REFRACTORY CHRONIC LYMPHOCYTIC-LEUKEMIA
Authors: BERGMANN L FENCHEL K JAHN B MITROU PS HOELZER D
Citation: L. Bergmann et al., IMMUNOSUPPRESSIVE EFFECTS AND CLINICAL-RESPONSE OF FLUDARABINE IN REFRACTORY CHRONIC LYMPHOCYTIC-LEUKEMIA, Annals of oncology, 4(5), 1993, pp. 371-375
TRANSFORMING GROWTH-FACTOR TRANSCRIPTION AND RELEASE BY AML BLAST CELLS MAY INDICATE AN IMMUNOSUPPRESSIVE POTENTIAL
Authors: BRIEGER J JAHN B FENCHEL K WEIDMANN E MITROU PS BERGMANN L
Citation: J. Brieger et al., TRANSFORMING GROWTH-FACTOR TRANSCRIPTION AND RELEASE BY AML BLAST CELLS MAY INDICATE AN IMMUNOSUPPRESSIVE POTENTIAL, Experimental hematology, 21(8), 1993, pp. 1046-1046
HIGH EXPRESSION OF ICAM-1 ON LEUKEMIC-CELLS AND UP-REGULATION OF ITS LIGANDS ON LYMPHOCYTES BY IL-2 IN PATIENTS WITH AML
Authors: FENCHEL K BRIEGER J WEIDMANN E MITROU PS BERGMANN L HOELZER D
Citation: K. Fenchel et al., HIGH EXPRESSION OF ICAM-1 ON LEUKEMIC-CELLS AND UP-REGULATION OF ITS LIGANDS ON LYMPHOCYTES BY IL-2 IN PATIENTS WITH AML, Experimental hematology, 21(8), 1993, pp. 1115-1115
INVERSION OF REMISSION DURATION IN 2ND REMISSION OF AML BY INTERLEUKIN-2 - THE ANTILEUCEMIC EFFECT MAY BE PREDOMINANTLY CAUSED BY AUTOLOGOUS CD4-CYTOTOXIC LYMPHOCYTES()
Authors: BERGMAN L JAHN B HEIL G KOLBE K LENGFELDER E LOHMEYER J FENCHEL K WEIDMANN E MITROU PS HOELZER D
Citation: L. Bergman et al., INVERSION OF REMISSION DURATION IN 2ND REMISSION OF AML BY INTERLEUKIN-2 - THE ANTILEUCEMIC EFFECT MAY BE PREDOMINANTLY CAUSED BY AUTOLOGOUS CD4-CYTOTOXIC LYMPHOCYTES(), Experimental hematology, 21(8), 1993, pp. 1119-1119
DAILY ALTERNATING ADMINISTRATION OF HIGH-DOSE INTERFERON-ALPHA-2B ANDINTERLEUKIN-2 BOLUS INFUSION IN METASTATIC RENAL-CELL CANCER - A PHASE-II STUDY
Authors: BERGMANN L FENCHEL K WEIDMANN E ENZINGER HM JAHN B JONAS D MITROU PS
Citation: L. Bergmann et al., DAILY ALTERNATING ADMINISTRATION OF HIGH-DOSE INTERFERON-ALPHA-2B ANDINTERLEUKIN-2 BOLUS INFUSION IN METASTATIC RENAL-CELL CANCER - A PHASE-II STUDY, Cancer, 72(5), 1993, pp. 1733-1742
PROGNOSTIC VALUE OF SIMULTANEOUS EXPRESSION OF CD7 AND CD33 ON LEUKEMIC BLASTS IN AML UNFAVORABLE OUTCOME OF PATIENTS WITH CD54+ BLASTS
Authors: FENCHEL K BERGMANN L CHRIST S WEIDMANN E BRIEGER J MITROU PS HOELZER D
Citation: K. Fenchel et al., PROGNOSTIC VALUE OF SIMULTANEOUS EXPRESSION OF CD7 AND CD33 ON LEUKEMIC BLASTS IN AML UNFAVORABLE OUTCOME OF PATIENTS WITH CD54+ BLASTS, Blood, 82(10), 1993, pp. 10000122-10000122
INTERLEUKIN-2 CONSOLIDATION THERAPY IN PATIENTS WITH 2ND REMISSION OFDE-NOVO ACUTE MYELOCYTIC-LEUKEMIA - RESULTS OF A MULTICENTER TRIAL
Authors: BERGMANN L FENCHEL K HEIL G KOLBE K LENGFELDER E BRUCHER J LOHMEYER J MITROU PS HOELZER D
Citation: L. Bergmann et al., INTERLEUKIN-2 CONSOLIDATION THERAPY IN PATIENTS WITH 2ND REMISSION OFDE-NOVO ACUTE MYELOCYTIC-LEUKEMIA - RESULTS OF A MULTICENTER TRIAL, Blood, 82(10), 1993, pp. 10000130-10000130
Risultati: 1-18 |